
Fred D. Zemel
Partner
201-896-7065 fzemel@sh-law.comFirm Insights
Author: Fred D. Zemel
Date: July 28, 2017
Partner
201-896-7065 fzemel@sh-law.comThe U.S. Supreme Court issued several key decisions involving intellectual property in its recently concluded October 2016 Term. From offensive trademarks to design patent, it was a landmark year for patent, trademark, and copyright decisions.
We provided in-depth coverage of many of the Supreme Court’s IP decisions on this website as well as the Constitutional Law Reporter. In case you missed any of our articles, below is a brief summary of several important cases:
In clarifying the patent exhaustion doctrine, the justices held that a patent holder’s decision to sell a product exhausts all of its patent rights in that item, regardless of any restrictions it purports to impose. The Court further found that an authorized sale exhausts all rights under the Patent Act regardless whether the product is sold inside or outside of the United States.
The Court held that patent infringement lawsuits must be filed where the defendant is incorporated. Reversing U.S. Court of Appeals for the Federal Circuit, the Court concluded that “a domestic corporation ‘resides’ only in its state of incorporation for purposes of the patent venue statute.”
The Court struck down the Lanham Act’s prohibition of registering disparaging trademarks with the U.S. Patent and Trademark Office, concluding that the ban was unconstitutional under the First Amendment.
The Court unanimously held that Section 262(l)(2)(A) of the Biologics Price Competition and Innovation Act of 2009 is not enforceable by injunction under federal law. However, it remanded the case to the Federal Circuit with instructions to determine whether a state-law injunction may be available. Reversing the Federal Circuit, the Court further held an applicant may provide notice of commercial marketing of a biosimilar under Section 262(l)(8)(A) prior to obtaining licensure from the U.S. Food and Drug Administration.
In addressing how to calculate damages in design patent infringement cases, the Court held that the Samsung could be liable for only those profits associated with the infringing components of the cell phone rather than the whole device. According to the unanimous Court, the relevant “article of manufacture” for determining damages award is not limited to the end product sold to the consumer, but may also be only a component of that product. The justices remanded the case back to the Federal Circuit to develop a test for determining whether the profits should apply to a product as a whole or its individual components. The Federal Circuit further delegated the task to the district court.
The Court held that the design of a cheerleading uniform is eligible for copyright protection. In so ruling, it established a two-part test to determine separability: “if the feature (1) can be perceived as a two- or three-dimensional work of art separate from the useful article and (2) would qualify as a protectable pictorial, graphic, or sculptural work either on its own or in some other medium if imagined separately from the useful article.”
The Court held that the equitable doctrine of “laches” does not bar a claim for patent infringement brought within the Patent Act’s six-year statutory limitations period.
The Court interpreted 35 U.S.C.§ 271(f)(1), which states it is an act of patent infringement to “suppl[y] …in or from the United States all or a substantial portion of the components of a patented invention, …in such manner as to actively induce the combination of such components outside the United States.” It held that patent infringement does not occur when a product is made abroad and all components but a single commodity article are also supplied from overseas.
Do you have any questions? Would you like to discuss the decisions further? If so, please contact me, Fred Zemel, at 201-806-3364.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Your home is likely your greatest asset, which is why it is so important to adequately protect it. Homeowners insurance protects you from the financial costs of unforeseen losses, such as theft, fire, and natural disasters, by helping you rebuild and replace possessions that were lost While the definition of “adequate” coverage depends upon a […]
Author: Jesse M. Dimitro
Making a non-contingent offer can dramatically increase your chances of securing a real estate transaction, particularly in competitive markets like New York City. However, buyers should understand that waiving contingencies, including those related to financing, or appraisals, also comes with significant risks. Determining your best strategy requires careful analysis of the property, the market, and […]
Author: Jesse M. Dimitro
Business Transactional Attorney Zemel to Spearhead Strategic Initiatives for Continued Growth and Innovation Little Falls, NJ – February 21, 2025 – Scarinci & Hollenbeck, LLC is pleased to announce that Partner Fred D. Zemel has been named Chair of the firm’s Strategic Planning Committee. In this role, Mr. Zemel will lead the committee in identifying, […]
Author: Scarinci Hollenbeck, LLC
Big changes sometimes occur during the life cycle of a contract. Cancelling a contract outright can be bad for your reputation and your bottom line. Businesses need to know how to best address a change in circumstances, while also protecting their legal rights. One option is to transfer the “benefits and the burdens” of a […]
Author: Dan Brecher
What is a trade secret and why you you protect them? Technology has made trade secret theft even easier and more prevalent. In fact, businesses lose billions of dollars every year due to trade secret theft committed by employees, competitors, and even foreign governments. But what is a trade secret? And how do you protect […]
Author: Ronald S. Bienstock
If you are considering the purchase of a property, you may wonder — what is title insurance, do I need it, and why do I need it? Even seasoned property owners may question if the added expense and extra paperwork is really necessary, especially considering that people and entities insured by title insurance make fewer […]
Author: Patrick T. Conlon
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
The U.S. Supreme Court issued several key decisions involving intellectual property in its recently concluded October 2016 Term. From offensive trademarks to design patent, it was a landmark year for patent, trademark, and copyright decisions.
We provided in-depth coverage of many of the Supreme Court’s IP decisions on this website as well as the Constitutional Law Reporter. In case you missed any of our articles, below is a brief summary of several important cases:
In clarifying the patent exhaustion doctrine, the justices held that a patent holder’s decision to sell a product exhausts all of its patent rights in that item, regardless of any restrictions it purports to impose. The Court further found that an authorized sale exhausts all rights under the Patent Act regardless whether the product is sold inside or outside of the United States.
The Court held that patent infringement lawsuits must be filed where the defendant is incorporated. Reversing U.S. Court of Appeals for the Federal Circuit, the Court concluded that “a domestic corporation ‘resides’ only in its state of incorporation for purposes of the patent venue statute.”
The Court struck down the Lanham Act’s prohibition of registering disparaging trademarks with the U.S. Patent and Trademark Office, concluding that the ban was unconstitutional under the First Amendment.
The Court unanimously held that Section 262(l)(2)(A) of the Biologics Price Competition and Innovation Act of 2009 is not enforceable by injunction under federal law. However, it remanded the case to the Federal Circuit with instructions to determine whether a state-law injunction may be available. Reversing the Federal Circuit, the Court further held an applicant may provide notice of commercial marketing of a biosimilar under Section 262(l)(8)(A) prior to obtaining licensure from the U.S. Food and Drug Administration.
In addressing how to calculate damages in design patent infringement cases, the Court held that the Samsung could be liable for only those profits associated with the infringing components of the cell phone rather than the whole device. According to the unanimous Court, the relevant “article of manufacture” for determining damages award is not limited to the end product sold to the consumer, but may also be only a component of that product. The justices remanded the case back to the Federal Circuit to develop a test for determining whether the profits should apply to a product as a whole or its individual components. The Federal Circuit further delegated the task to the district court.
The Court held that the design of a cheerleading uniform is eligible for copyright protection. In so ruling, it established a two-part test to determine separability: “if the feature (1) can be perceived as a two- or three-dimensional work of art separate from the useful article and (2) would qualify as a protectable pictorial, graphic, or sculptural work either on its own or in some other medium if imagined separately from the useful article.”
The Court held that the equitable doctrine of “laches” does not bar a claim for patent infringement brought within the Patent Act’s six-year statutory limitations period.
The Court interpreted 35 U.S.C.§ 271(f)(1), which states it is an act of patent infringement to “suppl[y] …in or from the United States all or a substantial portion of the components of a patented invention, …in such manner as to actively induce the combination of such components outside the United States.” It held that patent infringement does not occur when a product is made abroad and all components but a single commodity article are also supplied from overseas.
Do you have any questions? Would you like to discuss the decisions further? If so, please contact me, Fred Zemel, at 201-806-3364.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!